Related Experiment Video
Updated: Mar 3, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Management of Hypertension in Patients with Chronic Kidney Disease
1Division of Nephrology, Department of Medicine, Sidney Kimmel School of Medicine, Thomas Jefferson University, 833 Chestnut Street, Suite 700, Philadelphia, PA, 19107, USA. seyed.hamrahian@Jefferson.edu.
Insights
Hypertension significantly impacts global health, particularly in chronic kidney disease (CKD). Managing blood pressure (BP) in CKD involves complex mechanisms, individualized therapy, and careful drug selection for optimal outcomes.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Hypertension is a primary global health concern and a major risk factor for cardiovascular and kidney diseases.
- Chronic kidney disease (CKD) is intricately linked with hypertension, acting as both a cause and a consequence.
- The mechanisms driving hypertension in CKD are multifaceted and require thorough understanding.
Purpose of the Study:
- To review the pathogenic mechanisms of hypertension in CKD.
- To emphasize the importance of accurate blood pressure (BP) measurement and ambulatory BP monitoring in CKD management.
- To discuss current challenges and strategies for optimizing BP control in CKD patients.
Main Methods:
- Literature review focusing on pathogenic mechanisms of CKD-associated hypertension.
- Discussion of diagnostic and monitoring techniques, including standardized BP measurement and ambulatory BP monitoring.
- Analysis of therapeutic approaches, including lifestyle modifications, dietary interventions, and pharmacotherapy.
Main Results:
- CKD-associated hypertension involves complex, multi-factorial pathophysiological processes.
- Standardized BP measurement and ambulatory BP monitoring are crucial for diagnosis and management.
- Optimal BP targets in CKD are still debated, necessitating individualized treatment strategies.
- Effective management often requires a combination of antihypertensive drugs, tailored to patient comorbidities.
Conclusions:
- Understanding the complex pathophysiology of CKD-associated hypertension is essential for effective management.
- Accurate BP assessment and monitoring are critical components of care.
- Individualized therapeutic strategies, including combination pharmacotherapy and lifestyle modifications, are key to achieving optimal blood pressure control in patients with CKD.
Abstract:
Hypertension is the leading factor in the global burden of disease. It is the predominant modifiable risk factor for stroke, heart disease, and kidney failure. Chronic kidney disease (CKD) is both a common cause and sequel of uncontrolled hypertension. The pathophysiology of CKD-associated hypertension is complex and multi-factorial. This paper reviews the key pathogenic mechanisms of CKD-associated hypertension, the importance of standardized blood pressure (BP) measurement in establishing the diagnosis and management plus the significance of ambulatory BP monitoring for assessment of diurnal BP variation commonly seen in CKD. The optimal BP target in CKD remains a matter of discussion despite recent clinical trials. Medical therapy can be difficult and challenging. In addition to lifestyle modification and dietary salt restriction, treatment may need to be individualized based on co-morbidities. Combination of antihypertensive drugs, including appropriate diuretic choice and dose, is of great significance in hypertension management in CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury VI: Nursing Management
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications

